Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$3.76 - $5.14 $693,622 - $948,196
-184,474 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$4.81 - $8.74 $21,952 - $39,889
-4,564 Reduced 2.41%
184,474 $931,000
Q4 2020

Feb 16, 2021

SELL
$5.03 - $6.31 $38,238 - $47,968
-7,602 Reduced 3.87%
189,038 $995,000
Q3 2020

Nov 16, 2020

BUY
$4.67 - $11.0 $58,902 - $138,743
12,613 Added 6.85%
196,640 $1.03 Million
Q2 2020

Aug 14, 2020

BUY
$3.06 - $7.06 $131,586 - $303,594
43,002 Added 30.49%
184,027 $998,000
Q1 2020

May 14, 2020

SELL
$2.9 - $6.97 $104 - $250
-36 Reduced 0.03%
141,025 $524,000
Q3 2019

Nov 14, 2019

SELL
$7.7 - $10.42 $66,066 - $89,403
-8,580 Reduced 5.73%
141,061 $1.12 Million
Q2 2019

Aug 15, 2019

BUY
$8.29 - $13.22 $1.24 Million - $1.98 Million
149,641 New
149,641 $1.44 Million

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $106M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.